123 related articles for article (PubMed ID: 22349098)
21. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
[TBL] [Abstract][Full Text] [Related]
22. Post-transcriptional regulation of the expression of ferrochelatase by its variant mRNA.
Sakaino M; Kataoka T; Taketani S
J Biochem; 2009 Jun; 145(6):733-8. PubMed ID: 19251765
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
24. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation.
Kobuchi H; Moriya K; Ogino T; Fujita H; Inoue K; Shuin T; Yasuda T; Utsumi K; Utsumi T
PLoS One; 2012; 7(11):e50082. PubMed ID: 23189181
[TBL] [Abstract][Full Text] [Related]
26. Ferrochelatase activity and protoporphyrin IX utilization in Haemophilus influenzae.
Loeb MR
J Bacteriol; 1995 Jun; 177(12):3613-5. PubMed ID: 7768877
[TBL] [Abstract][Full Text] [Related]
27.
Xu L; Qi Q; Zhu J; Ma X
Chem Res Toxicol; 2022 Dec; 35(12):2186-2193. PubMed ID: 36459538
[No Abstract] [Full Text] [Related]
28. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
[TBL] [Abstract][Full Text] [Related]
29. Protoporphyrin IX: the Good, the Bad, and the Ugly.
Sachar M; Anderson KE; Ma X
J Pharmacol Exp Ther; 2016 Feb; 356(2):267-75. PubMed ID: 26588930
[TBL] [Abstract][Full Text] [Related]
30. Expression of peptide transporter 1 has a positive correlation in protoporphyrin IX accumulation induced by 5-aminolevulinic acid with photodynamic detection of non-small cell lung cancer and metastatic brain tumor specimens originating from non-small cell lung cancer.
Omoto K; Matsuda R; Nakai Y; Tatsumi Y; Nakazawa T; Tanaka Y; Shida Y; Murakami T; Nishimura F; Nakagawa I; Motoyama Y; Nakamura M; Fujimoto K; Hiroyuki N
Photodiagnosis Photodyn Ther; 2019 Mar; 25():309-316. PubMed ID: 30639584
[TBL] [Abstract][Full Text] [Related]
31. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.
Mirmiran A; Schmitt C; Lefebvre T; Manceau H; Daher R; Oustric V; Poli A; Lacapère JJ; Moulouel B; Puy H; Karim Z; Peoc'h K; Lenglet H; Simonin S; Deybach JC; Nicolas G; Gouya L
Am J Hum Genet; 2019 Feb; 104(2):341-347. PubMed ID: 30712775
[TBL] [Abstract][Full Text] [Related]
32. Differential gene content and gene expression for bacterial evolution and speciation of Shewanella in terms of biosynthesis of heme and heme-requiring proteins.
Dai J; Liu Y; Liu S; Li S; Gao N; Wang J; Zhou J; Qiu D
BMC Microbiol; 2019 Jul; 19(1):173. PubMed ID: 31362704
[TBL] [Abstract][Full Text] [Related]
33. Transgenic Tobacco Lines Expressing Sense or Antisense FERROCHELATASE 1 RNA Show Modified Ferrochelatase Activity in Roots and Provide Experimental Evidence for Dual Localization of Ferrochelatase 1.
Hey D; Ortega-Rodes P; Fan T; Schnurrer F; Brings L; Hedtke B; Grimm B
Plant Cell Physiol; 2016 Dec; 57(12):2576-2585. PubMed ID: 27818378
[TBL] [Abstract][Full Text] [Related]
34. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
35. Probing Hexaminolevulinate Mediated PpIX Fluorescence in Cancer Cell Suspensions in the Presence of Chemical Adjuvants.
Chan KM; Gleadle J; Vasilev K; MacGregor M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331454
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
[TBL] [Abstract][Full Text] [Related]
37. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice.
Lyoumi S; Abitbol M; Andrieu V; Henin D; Robert E; Schmitt C; Gouya L; de Verneuil H; Deybach JC; Montagutelli X; Beaumont C; Puy H
Blood; 2007 Jan; 109(2):811-8. PubMed ID: 17003376
[TBL] [Abstract][Full Text] [Related]
38. A continuous anaerobic fluorimetric assay for ferrochelatase by monitoring porphyrin disappearance.
Shi Z; Ferreira GC
Anal Biochem; 2003 Jul; 318(1):18-24. PubMed ID: 12782026
[TBL] [Abstract][Full Text] [Related]
39. Distribution of protoporphyrin IX in erythrocytes in a case of acquired erythropoietic protoporphyria.
Heerfordt IM; Fontenete S; Lerche CM; Wulf HC
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102629. PubMed ID: 34798346
[TBL] [Abstract][Full Text] [Related]
40. Porcine ferrochelatase: the relationship between iron-removal reaction and the conversion of heme to Zn-protoporphyrin.
Chau TT; Ishigaki M; Kataoka T; Taketani S
Biosci Biotechnol Biochem; 2010; 74(7):1415-20. PubMed ID: 20622448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]